Evaluation of the administration of CoQ10 tablets in poisoning with aluminum phosphide tablets
Phase 3
Recruiting
- Conditions
- Poisoning with aluminum phosphide tablets.Toxic effect of pesticides
- Registration Number
- IRCT20130917014693N14
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
People over 18 years old
People diagnosed with aluminum phosphide poisoning within 24 hours of being diagnosed with poisoning.
Signing the informed consent form by the patient or his / her legal guardian
Exclusion Criteria
Heart failure
Acute renal failure
Chronic liver failure
Chronic renal failure
History of acute myocardial infarction
Patients with a history of allergy to administered medicines
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death rate. Timepoint: Duraing the study. Method of measurement: Using the patient's clinical record.
- Secondary Outcome Measures
Name Time Method Changes in the results of arterial blood gas analysis. Timepoint: On a daily basis from the beginning of the drug administration to the end of the study. Method of measurement: The GEM Premier 3000 device is used to measure arterial blood gases.;Duration of hospitalization. Timepoint: On a daily basis from the beginning of the drug administration to the end of the study. Method of measurement: Using the patient's clinical record.;Blood pressure. Timepoint: On a daily basis from the beginning of the drug administration to the end of the study. Method of measurement: Sphygmomanometer.